| Oak Park Dental Group | |
|
12148 W 95th St Lenexa KS 66215-3805 | |
| (913) 492-9660 | |
| (913) 492-5899 |
| Full Name | Oak Park Dental Group |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 12148 W 95th St, Lenexa, Kansas |
| Authorized Official Name and Position | Steven Gregory Mitchell (PRESIDENT) |
| Authorized Official Contact | 9134929660 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Oak Park Dental Group 12148 W 95th St Lenexa KS 66215-3805 Ph: (913) 492-9660 | Oak Park Dental Group 12148 W 95th St Lenexa KS 66215-3805 Ph: (913) 492-9660 |
| NPI Number | 1346250321 |
|---|---|
| Provider Enumeration Date | 08/09/2006 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346250321 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Diabetes has become a major public health crisis in China, with an annual projected cost of 360 billion RMB (nearly 35 billion British pounds) by 2030, but a new collaborative approach to care that uses registries and community support could help improve diabetes care, according to a new three-part Series about diabetes in China published in The Lancet Diabetes & Endocrinology.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced initiation of patient enrollment in the second Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) in hemodialysis patients with secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease.
Today, Pharmacyclics LLC announced the results of the Phase III HELIOS trial (CLL3001), which found that patients with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who received ibrutinib (IMBRUVICA) in combination with bendamustine and rituximab (BR) experienced an 80% reduction in the risk of progression or death compared to patients receiving placebo in combination with BR.
Researchers at Georgetown University Medical Center have successfully used molecules comprised of small strands of RNA to shut down the production of destructive proteins generated by the COVID-19 virus.
› Verified 9 days ago
Kc Cone Beam, L.l.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 11900 W 87th Street Pkwy, Suite 128, Lenexa, KS 66215 Phone: 913-599-2228 Fax: 913-599-2229 | |
Ferns Rhoads Dds Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 10058 Woodland Dr, Lenexa, KS 66220 Phone: 913-800-2450 Fax: 913-800-2450 | |
Honey Bee Pdc Lenexa Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 10058 Woodland Dr, Lenexa, KS 66220 Phone: 314-882-2209 | |
Mint Dental Oak Park, Llc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 12148 W 95th St, Lenexa, KS 66215 Phone: 913-492-9660 | |
Theory Health Kansas Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 10000 Marshall Dr, Lenexa, KS 66215 Phone: 314-505-3005 | |
Andrew V Herwig Dds Pa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 11900 W 87th Street Pkwy Ste 260, Lenexa, KS 66215 Phone: 913-492-8884 Fax: 913-492-4582 | |
Dentists Of Lenexa Pa Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 8750 Loiret Blvd, Lenexa, KS 66219 Phone: 913-359-5146 Fax: 913-215-9409 |